Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Inotuzumab_ozogamicin> ?p ?o. }
Showing items 1 to 58 of
58
with 100 items per page.
- Inotuzumab_ozogamicin abstract "Inotuzumab ozogamicin (CMC-544) is an antibody-drug conjugate for the treatment of cancers. It consists of the humanized monoclonal antibody inotuzumab (for CD22), linked to a cytotoxic agent from the class of calicheamicins (which is reflected by 'ozogamicin' in the drug's name).This drug was developed by Wyeth.It is undergoing numerous clinical trials, including two phase II trials for Non-Hodgkin lymphoma (NHL). A phase III trial for NHL has been terminated due to 'poor enrollment'.".
- Inotuzumab_ozogamicin atcPrefix "none".
- Inotuzumab_ozogamicin casNumber "635715-01-4".
- Inotuzumab_ozogamicin fdaUniiCode "P93RUU11P7".
- Inotuzumab_ozogamicin wikiPageID "9685856".
- Inotuzumab_ozogamicin wikiPageRevisionID "544703300".
- Inotuzumab_ozogamicin atcPrefix "none".
- Inotuzumab_ozogamicin c "6518".
- Inotuzumab_ozogamicin casNumber "635715".
- Inotuzumab_ozogamicin chemspiderid "NA".
- Inotuzumab_ozogamicin h "10002".
- Inotuzumab_ozogamicin hasPhotoCollection Inotuzumab_ozogamicin.
- Inotuzumab_ozogamicin kegg "D08933".
- Inotuzumab_ozogamicin mabType "mab".
- Inotuzumab_ozogamicin molecularWeight "150000".
- Inotuzumab_ozogamicin n "1738".
- Inotuzumab_ozogamicin o "2036".
- Inotuzumab_ozogamicin s "42".
- Inotuzumab_ozogamicin source "zu/o".
- Inotuzumab_ozogamicin target CD22.
- Inotuzumab_ozogamicin type "mab".
- Inotuzumab_ozogamicin unii "P93RUU11P7".
- Inotuzumab_ozogamicin verifiedfields "changed".
- Inotuzumab_ozogamicin verifiedrevid "458271836".
- Inotuzumab_ozogamicin subject Category:Monoclonal_antibodies_for_tumors.
- Inotuzumab_ozogamicin subject Category:Wyeth.
- Inotuzumab_ozogamicin type Abstraction100002137.
- Inotuzumab_ozogamicin type Antibody115027189.
- Inotuzumab_ozogamicin type Chemical114806838.
- Inotuzumab_ozogamicin type Compound114818238.
- Inotuzumab_ozogamicin type Macromolecule114944888.
- Inotuzumab_ozogamicin type Material114580897.
- Inotuzumab_ozogamicin type Matter100020827.
- Inotuzumab_ozogamicin type Molecule114682133.
- Inotuzumab_ozogamicin type MonoclonalAntibodiesForTumors.
- Inotuzumab_ozogamicin type MonoclonalAntibody115029781.
- Inotuzumab_ozogamicin type OrganicCompound114727670.
- Inotuzumab_ozogamicin type Part113809207.
- Inotuzumab_ozogamicin type PhysicalEntity100001930.
- Inotuzumab_ozogamicin type Protein114728724.
- Inotuzumab_ozogamicin type Relation100031921.
- Inotuzumab_ozogamicin type Substance100019613.
- Inotuzumab_ozogamicin type Thing100002452.
- Inotuzumab_ozogamicin type Unit109465459.
- Inotuzumab_ozogamicin type Drug.
- Inotuzumab_ozogamicin type DrugProduct.
- Inotuzumab_ozogamicin type FunctionalSubstance.
- Inotuzumab_ozogamicin comment "Inotuzumab ozogamicin (CMC-544) is an antibody-drug conjugate for the treatment of cancers. It consists of the humanized monoclonal antibody inotuzumab (for CD22), linked to a cytotoxic agent from the class of calicheamicins (which is reflected by 'ozogamicin' in the drug's name).This drug was developed by Wyeth.It is undergoing numerous clinical trials, including two phase II trials for Non-Hodgkin lymphoma (NHL). A phase III trial for NHL has been terminated due to 'poor enrollment'.".
- Inotuzumab_ozogamicin label "Inotuzumab ozogamicin".
- Inotuzumab_ozogamicin label "Inotuzumab ozogamicin".
- Inotuzumab_ozogamicin label "إينوتوزوماب أوزوغاميسين".
- Inotuzumab_ozogamicin sameAs Inotuzumab_ozogamicin.
- Inotuzumab_ozogamicin sameAs m.02pp2z1.
- Inotuzumab_ozogamicin sameAs Q3799041.
- Inotuzumab_ozogamicin sameAs Q3799041.
- Inotuzumab_ozogamicin sameAs Inotuzumab_ozogamicin.
- Inotuzumab_ozogamicin wasDerivedFrom Inotuzumab_ozogamicin?oldid=544703300.
- Inotuzumab_ozogamicin isPrimaryTopicOf Inotuzumab_ozogamicin.